Related Experiment Video
Updated: Jun 7, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and
Zeynep Madak-Erdogan1, Mathieu Lupien, Fabio Stossi
1University of Illinois, Department of Molecular and Integrative Physiology, 407 South Goodwin Ave., Urbana, IL 61801-3704, USA.
Abstract:
The nuclear hormone receptor, estrogen receptor α (ERα), and mitogen-activated protein kinases (MAPKs) play key roles in hormone-dependent cancers, and yet their interplay and the integration of their signaling inputs remain poorly understood. In these studies, we document that estrogen-occupied ERα activates and interacts with extracellular signal-regulated kinase 2 (ERK2), a downstream effector in the MAPK pathway, resulting in ERK2 and ERα colocalization at chromatin binding sites across the genome of breast cancer cells. This genomic colocalization, predominantly at conserved distal enhancer sites, requires the activation of both ERα and ERK2 and enables ERK2 modulation of estrogen-dependent gene expression and proliferation programs. The ERK2 substrate CREB1 was also activated and recruited to ERK2-bound chromatin following estrogen treatment and found to cooperate with ERα/ERK2 in regulating gene transcription and cell cycle progression. Our study reveals a novel paradigm with convergence of ERK2 and ERα at the chromatin level that positions this kinase to support nuclear receptor activities in crucial and direct ways, a mode of collaboration likely to underlie MAPK regulation of gene expression by other nuclear receptors as well.
Insights
Estrogen receptor alpha (ERα) and extracellular signal-regulated kinase 2 (ERK2) colocalize at gene sites in breast cancer cells. This interaction regulates gene expression and cell proliferation, revealing a novel signaling pathway.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Estrogen receptor alpha (ERα) and mitogen-activated protein kinases (MAPKs) are crucial in hormone-dependent cancers.
- The precise interplay between ERα and MAPKs, particularly extracellular signal-regulated kinase 2 (ERK2), is not fully understood.
Purpose of the Study:
- To investigate the interaction between estrogen-activated ERα and ERK2 in breast cancer cells.
- To elucidate how this interaction influences gene expression and cellular processes at the genomic level.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) to identify genomic binding sites.
- Western blotting and immunofluorescence to assess protein activation and localization.
- Analysis of gene expression and cell cycle progression.
Main Results:
- Estrogen-occupied ERα activates and interacts with ERK2, leading to their colocalization at chromatin binding sites in breast cancer cells.
- This colocalization predominantly occurs at distal enhancer sites and is essential for ERK2's modulation of estrogen-dependent gene expression and proliferation.
- The ERK2 substrate CREB1 is activated and recruited to chromatin, cooperating with ERα/ERK2 to regulate transcription and cell cycle.
Conclusions:
- A novel mechanism of convergence between ERK2 and ERα at the chromatin level has been identified.
- ERK2 directly supports nuclear receptor activities, suggesting a broader role for MAPKs in regulating gene expression via other nuclear receptors.
Related Concept Videos
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
Cell Specific Gene Expression

